NASDAQ: DRIO
DarioHealth Corp.
Healthcare · Medical - Diagnostics & Research
Per-share valuation inputs need verification
Event dated Mar 31, 2026Market-derived shares outstanding and recent statement shares differ materially. Per-share ratios and valuation outputs may be unreliable until the share base is verified. This sometimes appears with ADRs or provider share-count gaps.
Market Cap
$59.13M
52w High
$17.74
52w Low
$5.94
P/E
5.08
Volume
8.48K
Outstanding Shares
7.30M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 43.87% over the last year. Revenue declined 24.41% over the trailing twelve months. Operating margin moved from 175.85% to -251.87%. Free cash flow grew 21.1% over the trailing twelve months.
What the market seems to be pricing
The market is reacting to weaker business momentum more than just compressing the valuation multiple. Even if the shares already screen cheap on P/S, investors are still discounting lower future earnings power.
What would invalidate this read
Operating margin stands at -251.87%. Revenue declined 24.41% — this read reverses if that trend stabilizes. If margins and cash flow stabilize while the stock stays depressed, the gap shifts from fundamental damage toward pure multiple compression.
Company profile
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.
Valuation
Stock splits
Every 20 shares became 1
Every 20 shares became 1
Every 1 shares became 18
Every 1 shares became 5
Profitability & growth
Analyst consensus
8
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 11, 2026
Q3 FY26 · EPS est -$1.13 · Revenue est $5.96M
View